Down-regulation of Stat3 induces apoptosis of human glioma cell: A potential method to treat brain cancer

Neurological Research

Volumn 30, Issue 3, 2008, Pages 297-301

  Ren, Wenwen ^a   Duan, Yanhong ^a   Yang, Yang ^a,b   Ji, Yonghua ^a   Chen, Fuxue ^a  

^a SHANGHAI UNIVERSITY   (China)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Glioma; RNAi; Stat3; TUNEL

Indexed keywords

RNA; STAT3 PROTEIN;

APOPTOSIS; ARTICLE; BRAIN CANCER; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CHEMICAL ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE THERAPY; GLIOMA CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RNA INTERFERENCE;

APOPTOSIS; CELL LINE, TUMOR; DOWN-REGULATION; GLIOMA; GREEN FLUORESCENT PROTEINS; HUMANS; RNA INTERFERENCE; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; TRANSFECTION;

EID: 44449097068     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164107X230784     Document Type: Article

References (27)

1. Levin VA, Leivel S, Gutin PH. Neoplasms of the central nervous system. In: DeVitt VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, Philadelphia, PA: Lippincott, 1997: pp. 2022-2082
2. Maher EA, Furnari FB, Bachoo RM, et al. Malignant glioma: Genetics and biology of a grave matter. Genes Dev 2001; 15: 1311-1333
3. Prados MD, Levin V. Biology and treatment of malignant glioma. Semin Oncol 2000; 27: 1-10
4. Holland EC. Glioblastoma multiforme: The terminator. Proc Natl Acad Sci 2000; 97: 6242-6244
5. Wechsler-Reya R, Scott MP. The developmental biology of brain tumors. Annu Rev Neurosci 2001; 24: 385-428
6. Roth JA, Cristiano RJ. Gene therapy for cancer: What have we done and where are we going? J Natl Cancer Inst 1997; 89: 21-39
7. Kleihues P, Ohgaki H. Genetics of glioma progression and the definition of primary and secondary glioblastoma. Brain Pathol 1997; 7: 1131-1136
8. Fueyo J, Gomez-Manzano C, Yung WK, et al. The functional role of tumor suppressor genes in gliomas: Clues for future therapeutic strategies. Neurology 1998; 51: 1250-1255
9. Gomez-Manzano C, Fueyo J, Kyritsis AP, et al. Tumor suppressor gene therapy or brain tumors. In: Chiocca EA, Breakefield X, eds. Gene Transfer and Therapy for Neurological Disorders, Totowa, NJ: Human Press, 1998
10. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943-1947
11. Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 12: 356-362
12. Ivanchuk SM, Mondal S, Dirks PB, et al. The INK4A/ARF locus: Role in cell cycle control and apoptosis and implications for glioma growth. J Neurooncol 2001; 51: 219-229
13. Ichimura K, Bolin MB, Goike HM, et al. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res 2000; 60: 417-424
14. Reifenberger G, Ichimura K, Reifenberger J, et al. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res 1996; 56: 5141-5145
15. Ramon A, Candelaria GM, Cristina B, et al. Gene therapy for gliomas: Molecular targets, adenoviral vectors, and oncolytic adenoviruses. Exp Cell Res 1999; 252: 1-12
16. Ihle JN. The Stat family in cytokine signaling. Curr Opin Cell Biol 2001; 13: 211-217
17. Levy DE, Lee CK. What does Stat3 do? J Clin Invest 2002; 109: 1143-1148
18. Takeda K, Akira S. STAT family of transcription factors in cytokine mediated biological responses. Cytokine Growth Factor Rev 2000; 11: 199-207
19. Darnell JE. STATs and gene regulation. Science 1997; 277: 1630-1635
20. Williams JG. STAT signalling in cell proliferation and in development. Curr Opin Genet Dev 2000; 10: 503-507
21. Bowman T, Garcia R, Turkson J, et al. STATs in oncogenesis. Oncogene 2000; 19: 2474-2488
22. Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogene. Cell 1999; 98: 295-303
23. Niwa H, Burdon T, Chambers I, et al. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 1998; 12: 2048-2060
24. Matsuda T, Nakamura T, Nakao K, et al. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J 1999; 18: 4261-4269
25. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual, New York: Cold Spring Harbor Laboratory Press, 2001
26. Chen F, Guo Q, Yang Y, et al. Inhibition of AF116909 gene expression enhances the differentiation of neural stem cells. Neurol Res 2005; 27: 557-561
27. Yang Y, Ren W, Chen F. Knockdown of Stat3 in C17.2 neural stem cells facilitates the generation of neurons: A possibility of transplantation with a low level of oncogene. Neuroreport 2006; 17: 235-238